Back to Search
ROY GULICK, MD, MPH
MD, MPH
Infectious Disease Physician
NPI: 1881731172IndividualAccepts Medicare
Specialties, Licenses & Credentials
Infectious Disease PhysicianPrimary
Internal Medicine — Infectious Disease
Code: 207RI0200X
173938(NY)
Education
COLUMBIA UNIVERSITY COLLEGE OF PHYSICIANS AND SURGEONS
Class of 1986
Research & Publications (20)
Maraviroc for previously treated patients with R5 HIV-1 infection.
PMID 18832244·N Engl J Med·2008
3-trial
Intensification of a triple-nucleoside regimen with tenofovir or efavirenz in HIV-1-infected patients with virological suppression.
PMID 17415036·AIDS·2007
4-observational
Antiretroviral management of treatment-naive patients.
PMID 17502230·Infect Dis Clin North Am·2007
8-other
Phase 2 study of the safety and efficacy of vicriviroc, a CCR5 inhibitor, in HIV-1-Infected, treatment-experienced patients: AIDS clinical trials group 5211.
PMID 17570119·J Infect Dis·2007
3-trial
Three- vs four-drug antiretroviral regimens for the initial treatment of HIV-1 infection: a randomized controlled trial.
PMID 16905783·JAMA·2006
2-rct
Triple-nucleoside regimens versus efavirenz-containing regimens for the initial treatment of HIV-1 infection.
PMID 15115831·N Engl J Med·2004
3-trial
Six-year follow-up of HIV-1-infected adults in a clinical trial of antiretroviral therapy with indinavir, zidovudine, and lamivudine.
PMID 14571186·AIDS·2003
3-trial
Structured treatment interruption in patients infected with HIV: a new approach to therapy.
PMID 11817971·Drugs·2002
6-review
Durability of response to treatment among antiretroviral-experienced subjects: 48-week results from AIDS Clinical Trials Group Protocol 359.
PMID 12195349·J Infect Dis·2002
3-trial
Treatment sequencing: use protease inhibitors first. IAPAC sessions 2001, July 18-19, 2001 - Chicago.
PMID 11708280·IAPAC Mon·2001
8-other
Indinavir, nevirapine, stavudine, and lamivudine for human immunodeficiency virus-infected, amprenavir-experienced subjects: AIDS Clinical Trials Group protocol 373.
PMID 11181147·J Infect Dis·2001
3-trial
3-year suppression of HIV viremia with indinavir, zidovudine, and lamivudine.
PMID 10877738·Ann Intern Med·2000
3-trial
When to switch and what to switch to: strategic use of antiretroviral therapy.
PMID 10758015·AIDS Read·2000
8-other
Randomized study of saquinavir with ritonavir or nelfinavir together with delavirdine, adefovir, or both in human immunodeficiency virus-infected adults with virologic failure on indinavir: AIDS Clinical Trials Group Study 359.
PMID 11023461·J Infect Dis·2000
3-trial
Quantitative deep sequencing reveals dynamic HIV-1 escape and large population shifts during CCR5 antagonist therapy in vivo.
PMID 19479085·PLoS One·2009
8-other
Assessing human immunodeficiency virus type 1 tropism: Comparison of assays using replication-competent virus versus plasma-derived pseudotyped virions.
PMID 19494074·J Clin Microbiol·2009
4-observational
Proteinuria, creatinine clearance, and immune activation in antiretroviral-naive HIV-infected subjects.
PMID 19591572·J Infect Dis·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- DIVISION OF INFECTIOUS DISEASES, WEILL CORNELL MEDICINE, 1300 YORK AVE
NEW YORK, NY 10065 - Phone
- (212) 746-6320
Quick Facts
- NPI
- 1881731172
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 2
- Years in Practice
- 40
- Publications
- 20
Are you this provider?
Claim Your Profile